Congress widens scrutiny of meningitis outbreak to regulator

Your Health Matters

A security guard looks out from the front doors of pharmaceutical compounding company NECC, a producer of the steroid methylprednisolone acetate, in Framingham, MassachusettsWASHINGTON (Reuters) – The House of Representatives on Friday widened its investigation into the deadly meningitis outbreak to include the role health regulators played in monitoring the pharmacy that produced steroid treatments suspected of causing the crisis. The House Energy and Commerce Committee called on the Massachusetts pharmacy board to tell congressional staff what it knew about the New England Compounding Center before the recall of more than 17,000 vials of sterile injectable steroid treatments for back and joint pain from health facilities in 23 states. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave